# A Study of TAK-341 in Treatment of Multiple System Atrophy

> **NCT05526391** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 159 (actual)

## Conditions studied

- Multiple System Atrophy

## Interventions

- **DRUG:** TAK-341
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05526391
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-09
- **Primary completion:** 2025-07-28
- **Final completion:** 2025-07-28
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05526391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05526391, "A Study of TAK-341 in Treatment of Multiple System Atrophy". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05526391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*